Historical Stock Price
ETFs Holding CHRS »    CHRS Split History »



Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/22/2024 $2.48 $2.49 $2.32 $2.33 2.08M
03/25/2024 $2.33 $2.40 $2.26 $2.28 1.92M
03/26/2024 $2.32 $2.39 $2.29 $2.30 4.94M
03/27/2024 $2.32 $2.44 $2.28 $2.42 2.58M
03/28/2024 $2.42 $2.51 $2.36 $2.39 2.09M
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.
CHRS historical stock prices picture
Coherus BioSciences (CHRS) has the following price history information. Looking back at CHRS historical stock prices for the last five trading days, on March 22, 2024, CHRS opened at $2.48, traded as high as $2.49 and as low as $2.32, and closed at $2.33. Trading volume was a total of 2.08M shares. On March 25, 2024, CHRS opened at $2.33, traded as high as $2.40 and as low as $2.26, and closed at $2.28. Trading volume was a total of 1.92M shares. On March 26, 2024, CHRS opened at $2.32, traded as high as $2.39 and as low as $2.29, and closed at $2.30. Trading volume was a total of 4.94M shares. On March 27, 2024, CHRS opened at $2.32, traded as high as $2.44 and as low as $2.28, and closed at $2.42. Trading volume was a total of 2.58M shares. On March 28, 2024, CHRS opened at $2.42, traded as high as $2.51 and as low as $2.36, and closed at $2.39. Trading volume was a total of 2.09M shares.

CHRS Historical Stock Prices By Date:

CHRS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Coherus BioSciences shares, starting with a $10,000 purchase of CHRS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/21/2014
End date: 03/28/2024
Start price/share: $13.05
End price/share: $2.39
Dividends collected/share: $0.00
Total return: -81.69%
Average Annual Total Return: -16.60%
Starting investment: $10,000.00
Ending investment: $1,830.76
Years: 9.35
Date Close
03/22/2024$2.33
03/25/2024$2.28
03/26/2024$2.30
03/27/2024$2.42
03/28/2024$2.39
CHRS is categorized under the Healthcare sector; below are some other companies in the same sector:

CHTP Historical Stock Prices
CIVI Historical Stock Prices
CKPT Historical Stock Prices
CLBS Historical Stock Prices
CLCD Historical Stock Prices
CLDN Historical Stock Prices
CLDX Historical Stock Prices
CLRB Historical Stock Prices
CLRBW Historical Stock Prices
CLSD Historical Stock Prices

Also explore: CHRS shares outstanding history

Email EnvelopeFree CHRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CHRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.